Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer

NCT03168139 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer
Metastatic Pancreatic Cancer

Interventions

DRUG: Olaptesed pegol - Monotherapy
DRUG: Olaptesed pegol + Pembrolizumab - Combination Therapy

Sponsor

TME Pharma AG

Collaborators

[object Object]